Chison Medical Technologies Co., Ltd. (688358.SS)
CNY 28.78
(0.14%)
CNY 28.78
(0.14%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -678.43 Million CNY | -54.16% |
| 2022 | -440.08 Million CNY | 0.99% |
| 2021 | -444.5 Million CNY | -48.03% |
| 2020 | -300.28 Million CNY | 71.76% |
| 2019 | -1.06 Billion CNY | -685.83% |
| 2018 | -135.3 Million CNY | -60.41% |
| 2017 | -84.35 Million CNY | -57.83% |
| 2016 | -53.44 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -934.5 Million CNY | -26.78% |
| 2024 Q3 | -945.46 Million CNY | -1.17% |
| 2024 Q1 | -737.08 Million CNY | -8.65% |
| 2023 Q4 | -678.43 Million CNY | -9.87% |
| 2023 FY | -678.43 Million CNY | -54.16% |
| 2023 Q3 | -617.46 Million CNY | -0.47% |
| 2023 Q2 | -614.6 Million CNY | -29.9% |
| 2023 Q1 | -473.14 Million CNY | -7.51% |
| 2022 Q4 | -440.08 Million CNY | 38.73% |
| 2022 Q3 | -718.3 Million CNY | -34.59% |
| 2022 Q2 | -533.69 Million CNY | 27.46% |
| 2022 Q1 | -735.76 Million CNY | -65.53% |
| 2022 FY | -440.08 Million CNY | 0.99% |
| 2021 FY | -444.5 Million CNY | -48.03% |
| 2021 Q1 | -1.03 Billion CNY | -241.06% |
| 2021 Q4 | -444.5 Million CNY | 42.05% |
| 2021 Q3 | -766.98 Million CNY | 21.79% |
| 2021 Q2 | -980.7 Million CNY | 4.8% |
| 2020 Q3 | -175.11 Million CNY | 69.73% |
| 2020 Q1 | -1.05 Billion CNY | 0.43% |
| 2020 FY | -300.28 Million CNY | 71.76% |
| 2020 Q4 | -302.04 Million CNY | -72.49% |
| 2020 Q2 | -578.49 Million CNY | 45.36% |
| 2019 Q4 | -1.06 Billion CNY | -1060.49% |
| 2019 Q3 | -91.62 Million CNY | -4.42% |
| 2019 Q1 | 135.3 Million CNY | 200.0% |
| 2019 FY | -1.06 Billion CNY | -685.83% |
| 2019 Q2 | -87.74 Million CNY | -164.85% |
| 2018 FY | -135.3 Million CNY | -60.41% |
| 2018 Q4 | -135.3 Million CNY | 0.0% |
| 2017 FY | -84.35 Million CNY | -57.83% |
| 2016 FY | -53.44 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Shenzhen Lifotronic Technology Co., Ltd. | -1.06 Billion CNY | 36.364% |